A Study of AK0529 in Adults Patients Hospitalized With RSV Infection

Summary

This is a randomized, double-blind, placebo-controlled, multicenter, phase II study to be conducted in adults hospitalized with RSV infection in China. The main objectives of this study are to investigate the safety, pharmacokinetics and efficacy of AK0529 in adult RSV patients.

Timeline

Start

2023-07-20

Primary completion

2024-06-28

Completion

2024-06-28

Drugs

Indications